• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Potential of chloroquine and hydroxychloroquine to treat COVID-19 causes fears of shortages among people with systemic lupus erythematosus.

作者信息

Jakhar Deepak, Kaur Ishmeet

机构信息

Department of Dermatology, North Delhi Municipal Corporation Medical College and Hindu Rao Hospital, New Delhi, India.

出版信息

Nat Med. 2020 May;26(5):632. doi: 10.1038/s41591-020-0853-0.

DOI:10.1038/s41591-020-0853-0
PMID:32269358
Abstract
摘要

相似文献

1
Potential of chloroquine and hydroxychloroquine to treat COVID-19 causes fears of shortages among people with systemic lupus erythematosus.氯喹和羟氯喹治疗新冠病毒疾病的潜力引发了系统性红斑狼疮患者对药物短缺的担忧。
Nat Med. 2020 May;26(5):632. doi: 10.1038/s41591-020-0853-0.
2
Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic: What Every Clinician Should Know.在 COVID-19 大流行期间使用羟氯喹和氯喹：每个临床医生都应该知道的事。
Ann Intern Med. 2020 Jun 2;172(11):754-755. doi: 10.7326/M20-1334. Epub 2020 Mar 31.
3
Possible Consequences of a Shortage of Hydroxychloroquine for Patients with Systemic Lupus Erythematosus amid the COVID-19 Pandemic.2019年冠状病毒病大流行期间羟氯喹短缺对系统性红斑狼疮患者的潜在后果
J Rheumatol. 2020 Jun 1;47(6):787-790. doi: 10.3899/jrheum.200395. Epub 2020 Apr 8.
4
Chiral switches of chloroquine and hydroxychloroquine: potential drugs to treat COVID-19.氯喹和羟氯喹的手性转换：治疗新冠肺炎的潜在药物
Drug Discov Today. 2020 Jul;25(7):1121-1123. doi: 10.1016/j.drudis.2020.04.021. Epub 2020 May 1.
5
Drug Evaluation during the Covid-19 Pandemic.新冠疫情期间的药物评估
N Engl J Med. 2020 Jun 11;382(24):2282-2284. doi: 10.1056/NEJMp2009457. Epub 2020 Apr 14.
6
Aminoquinolines against coronavirus disease 2019 (COVID-19): chloroquine or hydroxychloroquine.抗2019冠状病毒病（COVID-19）的氨基喹啉：氯喹或羟氯喹。
Int J Antimicrob Agents. 2020 Apr;55(4):105945. doi: 10.1016/j.ijantimicag.2020.105945. Epub 2020 Mar 17.
7
Hydroxychloroquine prophylaxis for COVID-19 contacts in India.印度针对新冠病毒病接触者的羟氯喹预防措施
Lancet Infect Dis. 2020 Oct;20(10):1118-1119. doi: 10.1016/S1473-3099(20)30313-3. Epub 2020 Apr 17.
8
Regulators split on antimalarials for COVID-19.监管机构在用于治疗新冠肺炎的抗疟疾药物问题上存在分歧。
Lancet. 2020 Apr 11;395(10231):1179. doi: 10.1016/S0140-6736(20)30817-5.
9
Use of chloroquine or hydroxychloroquine in treatment of COVID-19: is it ethical?使用氯喹或羟氯喹治疗新型冠状病毒肺炎：这是否符合伦理？
Cent Eur J Public Health. 2020 Sep;28(3):246-247. doi: 10.21101/cejph.a6464.
10
Chloroquine and Hydroxychloroquine in COVID-19: Practice Implications for Healthcare Professionals.氯喹和羟氯喹在2019冠状病毒病中的应用：对医疗保健专业人员的实践启示
J Coll Physicians Surg Pak. 2020 Oct;30(10):124-128. doi: 10.29271/jcpsp.2020.supp2.124.

引用本文的文献

1
Efficacy of Ivermectin, Chloroquine/Hydroxychloroquine, and Azithromycin in Managing COVID-19: A Systematic Review of Phase III Clinical Trials.伊维菌素、氯喹/羟氯喹及阿奇霉素治疗新冠肺炎的疗效：III期临床试验的系统评价
Biomedicines. 2024 Sep 27;12(10):2206. doi: 10.3390/biomedicines12102206.
2
Modulating effect of Eunkyo-san on expression of inflammatory cytokines and angiotensin-converting enzyme 2 in human mast cells.恩久善对人肥大细胞炎症细胞因子和血管紧张素转化酶 2 表达的调节作用。
In Vitro Cell Dev Biol Anim. 2024 Mar;60(2):195-208. doi: 10.1007/s11626-024-00847-w. Epub 2024 Jan 16.
3
Misinformation During the COVID-19 Outbreak in China: Cultural, Social and Political Entanglements.
新冠疫情期间中国的错误信息：文化、社会与政治纠葛
IEEE Trans Big Data. 2021 Jan 29;7(1):69-80. doi: 10.1109/TBDATA.2021.3055758. eCollection 2021 Mar 1.
4
Molecular mimicry, hyperactive immune system, and SARS-COV-2 are three prerequisites of the autoimmune disease triangle following COVID-19 infection.分子模拟、免疫系统亢进和 SARS-CoV-2 是 COVID-19 感染后引发自身免疫性疾病三角的三个前提条件。
Int Immunopharmacol. 2022 Nov;112:109183. doi: 10.1016/j.intimp.2022.109183. Epub 2022 Aug 22.
5
Protocol of Pakistan randomized and observational trial to evaluate coronavirus treatment among newly diagnosed patients with COVID-19: Azithromycin, Oseltamivir, and Hydroxychloquine.巴基斯坦一项评估新冠病毒19型（COVID-19）新诊断患者冠状病毒治疗方法的随机和观察性试验方案：阿奇霉素、奥司他韦和羟氯喹。
Pak J Med Sci. 2022 May-Jun;38(5):1401-1408. doi: 10.12669/pjms.38.5.5512.
6
DeepH-DTA: Deep Learning for Predicting Drug-Target Interactions: A Case Study of COVID-19 Drug Repurposing.深度H-DTA：用于预测药物-靶点相互作用的深度学习：以新冠病毒药物重新利用为例
IEEE Access. 2020 Sep 15;8:170433-170451. doi: 10.1109/ACCESS.2020.3024238. eCollection 2020.
7
Chronic use of hydroxychloroquine did not protect against COVID-19 in a large cohort of patients with rheumatic diseases in Brazil.慢性使用羟氯喹并未在巴西的一大群风湿疾病患者中预防 COVID-19。
Adv Rheumatol. 2021 Oct 7;61(1):60. doi: 10.1186/s42358-021-00217-0.
8
Challenges of Egyptian patients with systemic lupus erythematosus during the COVID-19 pandemic.埃及系统性红斑狼疮患者在新冠疫情期间面临的挑战。
Reumatologia. 2021;59(4):237-243. doi: 10.5114/reum.2021.108620. Epub 2021 Aug 20.
9
Clinical Dermatology and COVID-19 Pandemic: Narrative Review.临床皮肤病学与新冠疫情：叙述性综述
Indian J Dermatol. 2021 May-Jun;66(3):246-255. doi: 10.4103/ijd.ijd_463_21.
10
Environmental impacts of COVID-19 treatment: Toxicological evaluation of azithromycin and hydroxychloroquine in adult zebrafish.新型冠状病毒治疗的环境影响：阿奇霉素和羟氯喹对成年斑马鱼的毒理学评价。
Sci Total Environ. 2021 Oct 10;790:148129. doi: 10.1016/j.scitotenv.2021.148129. Epub 2021 May 29.